Thrive Capital, a venture capital firm based in Manhattan and run by Joshua Kushner, has raised $150 million for its latest fund as it seeks to raise its profile and become more competitive against larger firms.
The firm spent about 10 weeks raising the fund, receiving commitments from new and existing limited partners, a group that includes Princeton University, Hall Capital Partners and the Wellcome Trust.
The fund, which was oversubscribed, will operate under a broad mandate, with the flexibility to pursue early or later stage start-ups in the Internet sector. In total, Thrive has raised about $200 million across three funds.
“Thrive is opportunity driven,” Mr. Kushner, 27, said in an interview by phone. “We invest in assets as opposed to stage or geography.”
Mr. Kushner, son of the real estate magnate Charles Kushner and brother of Jared Kushner, owner of The New York Observer, has spent the last three years investing in social and e-commerce Internet start-ups.
He was an early backer of Fab.com, a flash sales site that recently raised $105 million; Hot Potato, which was sold to Facebook; and GroupMe, a messaging service acquired by Skype last year.
His firm was also one of the lead investors in Instagram’s $50 million financing round in April. The investment, which valued the photo-sharing service at half a billion dollars, was closed mere days before Facebook purchased the company for roughly $1 billion. However, the value of the deal, a combination of cash and stock, has since fallen as Facebook’s stock price declined sharply.
Though Mr. Kushner says he recognizes the weakness in the I.P.O. market, he remains bullish on the technology sector and the disruptive power of the Internet. And while Thrive has largely been defined by its consumer Internet plays, he said he was willing to invest in a broad array of start-ups, in the United States, Latin America or elsewhere.
“Many see the way the Internet has already transformed our daily lives and conclude that most of the change that was going to happen already has.” he said. “I am of the belief that it is only the beginning.”
The Wall Street Journal had earlier reported that Thrive was seeking to raise $150 million.
Rosneft is likely to conclude a deal or deals to take effective control of TNK-BP, and its plans could be announced Thursday.
A powerful family in Indonesia appears to have outmaneuvered the British financier Nathaniel Rothschild in a battle for control of the coal mining giant Bumi.
Data released Thursday offered some surprisingly positive news for retail sales and industrial output.
All coral species do not need photosynthesizing algae, a study suggests.
Prime Minister Wen Jiabao vowed in a speech this year that Beijing would pursue breaking up state monopolies. China's giant state enterprises, including the electric grid operator, have other ideas.
A "dark skies" movement, aimed at increasing the public's appreciation for stargazing, has gained strength in recent years, while cities are noticing that turning off streetlights can save money.
The decision by the BBC program “Newsnight” to cancel a segment looking into sexual abuse accusations against Jimmy Savile has led to a series of independent investigations.
Outrage followed a decision by Europe’s largest satellite providers to cease transmission of Iran’s 19 state-operated channels that broadcast to Europe and parts of the Middle East.
The heightened competition for keywords has driven up prices and made them harder for small companies to afford.
The start-up Art.sy aims to do for visual art what Pandora did for music: become a source of discovery, pleasure and education.
Jon Rimmerman sells $30 million worth of wine a year over e-mail. How? Well, let him tell you a little story about a young syrah he once swilled outside Walla Walla. …
The House Intelligence Committee said telecommunications equipment from Huawei Technologies and ZTE could be used for spying in the United States.
In a new approach to combating prescription painkiller abuse, the federal government is focusing on the middlemen between drug makers and the doctors and pharmacies that dispense drugs.
The bill, which allows the procedure during the first trimester for any reason, opens the way for one of the most sweeping abortion rights laws in Latin America.
In our zeal to single out the pharmaceutical industry's biases, we may have become blind to our own.
Sign up for the DealBook Newsletter, delivered every morning and afternoon, and receive breaking news alerts throughout the day.